(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

ACTIFOCUS

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

ACTIFOCUS

ST13

US500000088656767

Classe

1, 3, 5, 40

Pedido

88656767

Registro

6564978

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

31

Atualização mais recente

23/11/2021

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 3, 5, 40

Data de depósito

16/10/2019

Data de registro

23/11/2021

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

23/11/2021

Última transação

23/11/2021

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use, Foreign priority

Código do desenho

4

Tipo de titular

03

Localização do titular

Minato-ku, Tokyo, JP

Examinador

OAKES, ANNA JENNIE

Unidade examinadora

L30

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

F. C. (pessoa física)

Representantes

Suzanne M. Hengl BAKER BOTTS L.L.P.

Classificação técnica

Classes Nice

Classe 1Classe 3Classe 5Classe 40

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemical preparations for scientific purposesother than for medical or veterinary use; industrial chemicals; Chemicals for use in industry and science; chemical compositions for developingprinting and enlarging photographs; plant growth regulating preparations; fertilizers; Fatty acids used in the manufacture of pharmaceutical and cosmetic products; Liposomes used in the manufacture of pharmaceutical and cosmetic products; Chemicals additivesliposomes for use in the manufacture of pharmaceutical and cosmetic products; antibodies for in vitro scientific or research use; antibodies used in analyzing and detecting certain toxins or diseases for laboratory or research use; anti cancer nucleic acid for laboratory use; anti aging nucleic acid for laboratory use; anti-inflammatory nucleic acid for laboratory use; anti cancer peptide for laboratory use; anti aging peptide for laboratory use; anti-inflammatory peptide for laboratory use; anti cancer compounds for laboratory use; anti aging compounds for laboratory use; anti-inflammatory compounds for laboratory use; compounds used for analysis of angiogenesisother than for medical or veterinary use; cells for laboratory useother than for medical or veterinary use; liposome use for transfection of cells for scientific or research use; Chemical reagentsother than for medical or veterinary purposes

Classe 3

Cosmetics; skin soap; bath soap; deodorant soap; dishwasher detergents; laundry detergents; detergents for household use; dentifrices; fragrances and perfumery; essential oils for flavoring food and beverages; incense

Classe 5

Liposome for use in medical pharmaceutical preparations; Drug delivery agents in the form of liposomes that facilitate the delivery of pharmaceutical preparations and nucleotides; Drug delivery agents in the form of capsules that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of microcapsules composed of liposomes for the delivery of pharmaceutical preparations and nucleotides; liposome preparations for use in the delivery and release of pharmaceutical preparations; liposome reagents for transfection of cellsonly for medical and veterinary use; dietary supplements; dietetic beverages adapted for medical purposes; dietetic food adapted for medical purposes; dietary supplements for animals; antibodies for use in disease testing and pathology diagnosis

Classe 40

Processing of liposome pharmaceutical preparations composed of nucleotides; processing of liposome preparations composed of nucleotides; processing of pharmaceutical preparations for drug delivery system composed of liposomes for delivering nucleotides; processing of microcapsules for drug delivery system composed of liposomes for delivering nucleotides; processing of chemicals for drug delivery system composed of liposomes for delivering nucleotides; custom manufacture and processing of pharmaceuticals and chemicals for others; custom manufacture and processing of cosmetics and soaps for others

Publicações

Histórico de despachos e eventos da marca no USPTO.

31 publicações encontradas

R.PR

REGISTERED-PRINCIPAL REGISTER

23/11/2021

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

19/10/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

19/10/2021

IUCN

NOTICE OF ALLOWANCE CANCELLED

05/10/2021

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

05/10/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

03/08/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/06/2021

PUBO

PUBLISHED FOR OPPOSITION

08/06/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

19/05/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/05/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

29/04/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

29/04/2021

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

26/04/2021

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

01/02/2021

GNSL

LETTER OF SUSPENSION E-MAILED

01/02/2021

CNSL

SUSPENSION LETTER WRITTEN

01/02/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

25/01/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

25/01/2021

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

22/01/2021

DOCK

ASSIGNED TO EXAMINER

31/08/2020

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

23/07/2020

GNSI

INQUIRY TO SUSPENSION E-MAILED

23/07/2020

CNSI

SUSPENSION INQUIRY WRITTEN

23/07/2020

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

18/07/2020

ALIE

ASSIGNED TO LIE

29/06/2020

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

05/12/2019

GNSL

LETTER OF SUSPENSION E-MAILED

05/12/2019

CNSL

SUSPENSION LETTER WRITTEN

05/12/2019

DOCK

ASSIGNED TO EXAMINER

03/12/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

20/10/2019

NWAP

NEW APPLICATION ENTERED

19/10/2019

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace ACTIFOCUS ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.